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Background
Since 2011 Clostridium difficile infection (CDI) has been
an emerging nosocomial problem in Romanian hospitals,
due to its growing incidence and severity. Objectives: To
describe risk factors and clinical outcome for CDI cases,
and strains characterization.
Methods
We collected data for all 398 confirmed or probable cases
of CDI admitted during 15 November 2013-28 February
2014 in 11 hospitals: 5 from Bucharest, and 7 from Cluj,
Iaşi, Timişoara, Târgu Mureş and Braşov. PCR ribotyping
was performed at Cantacuzino Institute and E-test (for
moxifloxacin and metronidazole) and binary toxin gene
identification (PCR) were performed at Matei Balş Institute.
The hospitals sent a maximum 20 feces samples for each
test.
Results
Mean age was 63.4 years (range 1-94 years), and sex ratio
F:M=1.08:1. For 40 patients, CDI were community-
acquired, 12.5% CI95% (9.3%-16.6%), if indeterminate ori-
gin cases were excluded; 12 of 13 strains tested from these
patients were ribotype 027 and/or binary toxin positive. A
post-antibiotic CDI were documented in 346/385 analyz-
able cases, 89.9% CI95% (86.5%-92.5%); 53.6% of them
received medication from at least two different antibiotic
groups. The most utilized antibiotics were cephalosporins
and quinolones. In 13.1% cases with known history, the
CDI episode was a recurrent one CI95% (10.1%-17%); bin-
ary toxin was retrieved in all six tested strains from recur-
rent CDI. A number of 45 episodes were considered severe
CDI (25 deaths, 7 intensive care required, 6 colectomies,
7 patients discharged with worsened condition), 12.1%
from 371 episodes with identified outcome CI95%
(9.2%-15.8%). From 155 tested strains, 122 belonged to 027
ribotype and/or were binary toxin positive, 78.7% CI95%
(71.6%-84.4%); the remaining 33 strains belonged to ribo-
types 002 (n=4), 014 (n=2), 018 (n=2), 087 (n=2), one
isolate each 001, 011, 012, 017, 020, 106 ribotypes and
17 strains were binary toxin negatives. The 027 ribotype
and/or binary toxin presence were prevalent in all hospi-
tals, ranging from 69.7% to 100%. In 62 of 84 tested iso-
lates, the MIC for moxifloxacin was greater than 2 mg/L,
the epidemiological cut-off value, more frequent in ribotype
027 or binary toxin positive strains, RR=2.02 (1.27; 3.22),
p<0.0001.
Conclusion
The severe CDI episodes were relatively frequent in our
study. The main risk factor for CDI was the previous
antibiotic treatment, especially with cephalosporins and
quinolones. The wide circulation of 027 ribotype could
explain the persistence of hospital outbreaks of CDI and
the increase of community-acquired CDI episodes. No
discrepancies were noticed among participant hospitals.
Authors’ details
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
2National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest,
Romania. 3National Institute of Public Health, Bucharest, Romania.* Correspondence: gabrielp9@yahoo.com
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Full list of author information is available at the end of the article
Popescu et al. BMC Infectious Diseases 2014, 14(Suppl 7):O24
http://www.biomedcentral.com/1471-2334/14/S7/O24
© 2014 Popescu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
4Cantacuzino National Institute for Research and Development for
Microbiology and Immunology, Bucharest, Romania.
Published: 15 October 2014
doi:10.1186/1471-2334-14-S7-O24
Cite this article as: Popescu et al.: Clinical and microbiological
characterization of Clostridium difficile infection in Romania (2013-2014);
a hospital-based study. BMC Infectious Diseases 2014 14(Suppl 7):O24.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Popescu et al. BMC Infectious Diseases 2014, 14(Suppl 7):O24
http://www.biomedcentral.com/1471-2334/14/S7/O24
Page 2 of 2
